S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
Log in

ValiRx News Headlines (LON:VAL)

GBX 0.14
0.00 (0.00 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
0.13
Now: GBX 0.14
0.14
50-Day Range
0.13
MA: GBX 0.16
0.25
52-Week Range
0.12
Now: GBX 0.14
2
Volume23.78 million shs
Average Volume3.82 million shs
Market Capitalization£1.38 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

ValiRx (LON VAL) News Headlines

Source:
DateHeadline
ValiRx Raises GBP350,000 Through Placing To Progress Clinical TrialsValiRx Raises GBP350,000 Through Placing To Progress Clinical Trials
www.lse.co.uk - October 14 at 10:46 AM
Placing & Issue of EquityPlacing & Issue of Equity
www.lse.co.uk - October 14 at 10:46 AM
ValiRx Reports Narrowed Loss In First Half As Expenses ReduceValiRx Reports Narrowed Loss In First Half As Expenses Reduce
www.morningstar.co.uk - September 26 at 5:19 PM
ValiRx Receives GBP423,000 Research & Development Credit From UK HMRCValiRx Receives GBP423,000 Research & Development Credit From UK HMRC
www.morningstar.co.uk - September 24 at 5:37 PM
ValiRx Prostate Cancer Drug VAL201 Still Meeting EndpointsValiRx Prostate Cancer Drug VAL201 Still Meeting Endpoints
www.morningstar.co.uk - September 10 at 3:34 PM
Global Epigenetics Drugs and Diagnostic Technologies Market 2019- Celenge, Eisai Pharmaceuticals, PharmacyclicsGlobal Epigenetics Drugs and Diagnostic Technologies Market 2019- Celenge, Eisai Pharmaceuticals, Pharmacyclics
www.marketwatch.com - August 12 at 5:09 PM
What Kind Of Investor Owns Most Of ValiRx plc (LON:VAL)?What Kind Of Investor Owns Most Of ValiRx plc (LON:VAL)?
finance.yahoo.com - August 7 at 12:01 PM
ValiRx Joint Venture Discussions With Alpha Blue Ocean StallValiRx Joint Venture Discussions With Alpha Blue Ocean Stall
www.morningstar.co.uk - August 6 at 10:50 AM
ValiRx Granted European Patent Allowance For VAL301 CompoundValiRx Granted European Patent Allowance For VAL301 Compound
www.morningstar.co.uk - August 1 at 12:35 PM
Monecor Takes Nearly 6% Holding In Biotechnology Firm ValiRxMonecor Takes Nearly 6% Holding In Biotechnology Firm ValiRx
www.morningstar.co.uk - July 23 at 12:03 PM
ValiRx Signs Clinical Development Deal For VAL301 In EndometriosisValiRx Signs Clinical Development Deal For VAL301 In Endometriosis
www.morningstar.co.uk - July 4 at 10:18 AM
US Grands Patent Claim For valiRxs VAL201 In Metastatic CancerUS Grands Patent Claim For valiRx's VAL201 In Metastatic Cancer
www.morningstar.co.uk - June 26 at 10:38 AM
ValiRx Cancels Subscription Agreement With European High GrowthValiRx Cancels Subscription Agreement With European High Growth
www.morningstar.co.uk - June 25 at 5:12 PM
ValiRx VAL201 Trial Protocol Amended With Dosing Restrictions RelaxedValiRx VAL201 Trial Protocol Amended With Dosing Restrictions Relaxed
www.morningstar.co.uk - June 20 at 10:26 AM
ValiRx Subscription Raises GBP300,000 For Drug Trial And Development (ALLISS)ValiRx Subscription Raises GBP300,000 For Drug Trial And Development (ALLISS)
www.morningstar.co.uk - June 13 at 12:06 PM
ValiRx In Discussions With Investor To End Subscription Agreement (ALLISS)ValiRx In Discussions With Investor To End Subscription Agreement (ALLISS)
www.morningstar.co.uk - June 10 at 11:10 AM
ValiRx Convertible Bond Talks In Advanced Stage; Plans Open Offer (ALLISS)ValiRx Convertible Bond Talks In Advanced Stage; Plans Open Offer (ALLISS)
www.morningstar.co.uk - June 5 at 10:10 AM
ValiRx Cancels Subscription, To Seek New Facility With Same Investor (ALLISS)ValiRx Cancels Subscription, To Seek New Facility With Same Investor (ALLISS)
www.morningstar.co.uk - June 2 at 9:57 AM
ValiRx Extends Talks With Investor Over New Convertible Bond (ALLISS)ValiRx Extends Talks With Investor Over New Convertible Bond (ALLISS)
www.morningstar.co.uk - May 31 at 10:24 AM
ValiRx Annual Loss Widens On Higher Costs And Fair Value LossesValiRx Annual Loss Widens On Higher Costs And Fair Value Losses
www.morningstar.co.uk - May 29 at 10:12 AM
Acquisition of Intellectual Property& JV AgreementAcquisition of Intellectual Property& JV Agreement
www.lse.co.uk - May 2 at 10:31 AM
ValiRx Partners With Alpha Blue Ocean And Buys IP Assets Of FIT BioValiRx Partners With Alpha Blue Ocean And Buys IP Assets Of FIT Bio
www.lse.co.uk - May 2 at 10:31 AM
Very good articleVery good article
www.lse.co.uk - April 27 at 10:26 AM
Oh no not again - Death spiral ahoyOh no not again - Death spiral ahoy
www.lse.co.uk - April 26 at 10:17 AM
ValiRx To Raise GBP1 Million Under Deal With European High Growth (ALLISS)ValiRx To Raise GBP1 Million Under Deal With European High Growth (ALLISS)
www.lse.co.uk - April 26 at 10:17 AM
The ValiRx (LON:VAL) Share Price Is Down 98% So Some Shareholders Are Very SaltyThe ValiRx (LON:VAL) Share Price Is Down 98% So Some Shareholders Are Very Salty
finance.yahoo.com - April 10 at 5:26 PM
Member Info for gordongecko666Member Info for gordongecko666
www.lse.co.uk - March 22 at 5:22 PM
ValiRx Notes Encouraging Performance Of VAL201 In Cancer TrialValiRx Notes Encouraging Performance Of VAL201 In Cancer Trial
www.morningstar.co.uk - March 21 at 9:16 AM
Member Info for giesachanceMember Info for giesachance
www.lse.co.uk - March 2 at 10:00 AM
ValiRx Raises GBP500,000 Through Placing To Advance Clinical Trials (ALLISS)ValiRx Raises GBP500,000 Through Placing To Advance Clinical Trials (ALLISS)
www.morningstar.co.uk - February 21 at 11:56 AM
New patent grant allowances for VAL301New patent grant allowances for VAL301
www.lse.co.uk - January 31 at 10:07 AM
ValiRx Secures Patent For VAL301 Compound In Russia And ChinaValiRx Secures Patent For VAL301 Compound In Russia And China
www.morningstar.co.uk - January 31 at 10:07 AM
ValiRx Backs New Long-Term UK Government Plan For NHSValiRx Backs New Long-Term UK Government Plan For NHS
www.morningstar.co.uk - January 9 at 10:16 AM
ValiRx Raises GBP500,000 In Placing For Clinical Trials (ALLISS)ValiRx Raises GBP500,000 In Placing For Clinical Trials (ALLISS)
www.morningstar.co.uk - December 18 at 4:15 PM
Re scientific and investor meetingsRe scientific and investor meetings
www.lse.co.uk - November 5 at 10:31 AM
ValiRX Enters Concluding Stages Of VAL201 Clinical TrialValiRX Enters Concluding Stages Of VAL201 Clinical Trial
www.morningstar.co.uk - October 17 at 9:45 AM
ValiRx plc (LON:VAL): What Does The Future Look Like?ValiRx plc (LON:VAL): What Does The Future Look Like?
finance.yahoo.com - September 18 at 10:00 AM
ValiRx Says Clinical Study For Lung Cancer Drug VAL401 Is ApprovedValiRx Says Clinical Study For Lung Cancer Drug VAL401 Is Approved
www.morningstar.co.uk - September 6 at 10:17 AM
ValiRx Shares Rise As Advances Discussions For VAL401 Commercial UseValiRx Shares Rise As Advances Discussions For VAL401 Commercial Use
www.morningstar.co.uk - June 14 at 9:52 AM
VAL. received fromVAL. received from
www.lse.co.uk - June 8 at 3:59 PM
Did ValiRx plc’s (LON:VAL) Recent Earnings Growth Beat The Trend?Did ValiRx plc’s (LON:VAL) Recent Earnings Growth Beat The Trend?
finance.yahoo.com - May 25 at 4:04 PM
Nicholas Slater Increases ValiRx Stake To 4.5% From 2.7% (ALLISS)Nicholas Slater Increases ValiRx Stake To 4.5% From 2.7% (ALLISS)
www.morningstar.co.uk - May 11 at 3:56 PM
VAL. ValiRx Plc (AI-VAL. ValiRx Plc (AI-
www.lse.co.uk - April 25 at 10:21 AM
"Major" Milestone As ValiRxs VAL201 Is Granted Patent In EU"Major" Milestone As ValiRx's VAL201 Is Granted Patent In EU
www.morningstar.co.uk - April 25 at 10:21 AM
VAL. Firstly I than-VAL. Firstly I than-
www.lse.co.uk - April 22 at 4:30 PM
VAL. Thanks for pre-VAL. Thanks for pre-
www.lse.co.uk - April 20 at 10:21 AM
ValiRx 2017 Loss Narrows Amid Costs Decline As Products ProgressValiRx 2017 Loss Narrows Amid Costs Decline As Products Progress
www.morningstar.co.uk - April 10 at 10:31 AM
Member Info for waytodeepMember Info for waytodeep
www.lse.co.uk - March 19 at 10:19 AM
YA II CD Lowers ValiRx Interest To Below 3% Threshold (ALLISS)YA II CD Lowers ValiRx Interest To Below 3% Threshold (ALLISS)
www.morningstar.co.uk - March 19 at 10:19 AM
Appointment of Broker - London South East (blog)Appointment of Broker - London South East (blog)
www.lse.co.uk - March 17 at 4:27 PM
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: What are Bollinger Bands?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel